PIMA542104
Lanadelumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542104-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542104 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Lanadelumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
DX-2930; X124-G01
Immunogen
Human KLKB1
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
3.16 mg/mL
Formulation
PBS with no preservative; pH 7.5
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Lanadelumab, also known as DX-2930, is a human IgG1 monoclonal antibody designed for subcutaneous self-injection
- It is a fully human immunoglobulin, k-light-chain made in recombinant Chinese Hamster Ovary cells
- The FDA and EU granted the designation of priority review, breakthrough therapy and orphan pharmaceutical for rare diseases based on the results of the reported clinical trials
- Lanadelumab was developed by Shire and FDA approved on August 28, 2018
- 5.
Compare Similar Items
Show Difference
Antigen: Lanadelumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: DX-2930; X124-G01
Immunogen: Human KLKB1
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.16 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Lanadelumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
DX-2930; X124-G01
Immunogen:
Human KLKB1
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.16 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Vonlerolizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: MOXR0916; MOXR-0916; RG-7888; RO7021608
Immunogen: Human TNFRSF4/CD134
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.66 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Vonlerolizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
MOXR0916; MOXR-0916; RG-7888; RO7021608
Immunogen:
Human TNFRSF4/CD134
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.66 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Galcanezumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: galcanezumab-gnlm; LY-2951742
Immunogen: Human CALCA/CGRP1/CALCB/CGRP2
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 4.03 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Galcanezumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
galcanezumab-gnlm; LY-2951742
Immunogen:
Human CALCA/CGRP1/CALCB/CGRP2
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
4.03 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Domagrozumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: PF-06252616
Immunogen: Human MSTN /GDF8
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.98 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Domagrozumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
PF-06252616
Immunogen:
Human MSTN /GDF8
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.98 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ